Common Stock, par value $0.001 per share
- Symbol
- BGMS
- Exchange
- NASDAQ
- Classification
- COMMON
- Status
- Current
Current Report · Items 2.02, 9.01 · 8-K
Bio Green Med Solution, Inc.
BGMSNASDAQEQUITYCurrent
Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition. On November 12, 2026, Bio Green Med Solution, Inc. (the “Company”) issued a press release announcing its financial results for the third quarter ended September 30, 2026 and providing a business update. On the same date, the Company filed its Quarterly Report on Form 10-Q for the quarter ended September 30, 2026 with the Securities and Exchange Commission.…
Press release in this filing
BIO GREEN MED SOLUTION Reports THIRD quarter financial results and provides business update →Company context
We are a clinical-stage biopharmaceutical company working to develop innovative cancer medicines based on cell cycle, epigenetics and mitosis biology. We are a pioneer company in the field of cancer cell cycle biology with a vision to improve patient healthcare by translating insights in cancer biology into medicines that can overcome resistance and ultimately increase a patient’s overall survival.
Current securities
Registered securities in this filing
Bio Green Med Solution, Inc. · 8-K · Filed 2026-11-12
Disclosure sections
Item 2.02Item 2.02 - Results of Operations
Item
2.02 Results of Operations and Financial Condition.
On
November 12, 2026, Bio Green Med Solution, Inc. (the “Company”) issued a press release announcing its financial results for
the third quarter ended September 30, 2026 and providing a business update. On the same date, the Company filed its Quarterly Report
on Form 10-Q for the quarter ended September 30, 2026 with the Securities and Exchange Commission. A copy of the press release is furnished
as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
The
information in this Item 2.02, including Exhibit 99.1, is being furnished and shall not be deemed “filed” for purposes of
Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities
of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the
Exchange Act, except as expressly set forth by specific reference in such a filing.
Filed exhibits (1)
Exhibit 99.1 BIO GREEN MED SOLUTION Reports THIRD quarter financial results and provides business update KUALA LUMPUR, MALAYSIA, November 12, 2026 - Bio Green Med Solution, Inc. (NASDAQ: BGMS; “BGMS” or the “Company”), a diversified company engaged primarily in the provision of fire safety protection and distribution activities, today announced third quarter financial results and provided a business update. Highlights of the third quarter ended September 30, 2026, or in some cases shortly thereafter, include: In October, the Company’s previously filed Form S-4, detailing the Company’s proposed Business Combination Agreement with Future NRG Sdn. Bhd., a Malaysia private limited company, was declared effective. The Company is planning to hold a Special Meeting in November 2026 to obtain shareholder approval for the proposed Business Combination. ───────────────────────────────────────────────────────────────────────────────────────────────── In October, the Board of Directors of the Company declared a quarterly cash dividend of $0.15 per share on the Company’s 6% Convertible Exchangeable Preferred Stock, which cash dividend was paid on November 1, 2026, to hold…
Open exhibit ↗